Literature DB >> 16126198

Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man.

Andoni Echaniz-Laguna1, Joffrey Zoll, Elodie Ponsot, Benoit N'guessan, Christine Tranchant, Jean-Philippe Loeffler, Eliane Lampert.   

Abstract

We performed repeated analysis of mitochondrial respiratory function in skeletal muscle (SM) of patients with early-stage sporadic amyotrophic lateral sclerosis (SALS) to determine whether mitochondrial function was altered as the disease advanced. SM biopsies were obtained from 7 patients with newly diagnosed SALS, the same 7 patients 3 months later, and 7 sedentary controls. Muscle fibers were permeabilized with saponin, then skinned and placed in an oxygraphic chamber to measure basal and maximal adenosine diphosphate (ADP)-stimulated respiration rates and to assess mitochondrial regulation by ADP. We found that the maximal oxidative phosphorylation capacity of muscular mitochondria significantly increased, and muscular mitochondrial respiratory complex IV activity significantly decreased as the disease advanced. This temporal study demonstrates for the first time that mitochondrial function in SM in human SALS is progressively altered as the disease develops.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126198     DOI: 10.1016/j.expneurol.2005.07.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  39 in total

Review 1.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

2.  Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis.

Authors:  Raquel Manzano; Janne M Toivonen; Ana Cristina Calvo; Sara Oliván; Pilar Zaragoza; Maria Jesús Muñoz; Didier Montarras; Rosario Osta
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

3.  ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression.

Authors:  Yajuan Xiao; Chehade Karam; Jianxun Yi; Lin Zhang; Xuejun Li; Dosuk Yoon; Huan Wang; Kamal Dhakal; Paul Ramlow; Tian Yu; Zhaohui Mo; Jianjie Ma; Jingsong Zhou
Journal:  Pharmacol Res       Date:  2018-09-18       Impact factor: 7.658

4.  Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients.

Authors:  Johannes K Ehinger; Saori Morota; Magnus J Hansson; Gesine Paul; Eskil Elmér
Journal:  J Neurol       Date:  2015-04-18       Impact factor: 4.849

Review 5.  Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.

Authors:  Lee J Martin; Margaret Wong
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 6.  Mitochondrial pathobiology in ALS.

Authors:  Lee J Martin
Journal:  J Bioenerg Biomembr       Date:  2011-12       Impact factor: 2.945

7.  Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.

Authors:  Margaret Wong; Lee J Martin
Journal:  Hum Mol Genet       Date:  2010-03-10       Impact factor: 6.150

8.  Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.

Authors:  Lee J Martin
Journal:  Pharmaceuticals (Basel)       Date:  2010

9.  Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.

Authors:  Christian Lunetta; Andrea Lizio; Lucio Tremolizzo; Massimiliano Ruscica; Chiara Macchi; Nilo Riva; Patrick Weydt; Ettore Corradi; Paolo Magni; Valeria Sansone
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

Review 10.  The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.

Authors:  Lee J Martin
Journal:  Biochim Biophys Acta       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.